Persica Pharmaceuticals announces positive Phase 1b clinical data for PP353, a novel, non-opioid intradiscal injection for the treatment of chronic Low Back Pain
Persica Pharmaceuticals announces positive Phase 1b clinical data for PP353, a novel,…
Chronic Pain Centre of Excellence for Canadian Veterans and Bayshore HealthCare Unite to Support Veterans at Invictus Games Vancouver Whistler 2025
HAMILTON, Ontario, Feb. 03, 2025 (GLOBE NEWSWIRE) -- The Chronic Pain Centre…